Monitoring tumor response to antiangiogenic sunitinib therapy with 18F-fluciclatide, an 18F-labeled ?Vbeta3-integrin and ?V beta5-integrin imaging agent.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples